Pasar al contenido principal

MODELIZACION MATEMATICA DE PROCESOS BIOLOGICOS E INDUSTRIALES: SIMULACION NUMERICA Y TRATAMIENTO DE SEÑALES

PID2020-117211GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes

  • Andreu, Zoraida
  • Hidalgo, Marta R.
  • Masia, Esther
  • Romera-Giner, Sergio
  • Malmierca-Merlo, Pablo
  • López-Guerrero, José A.
  • García-García, Francisco
  • Vicent, María J.
[EN] Identifying novel breast cancer biomarkers will improve patient stratification, enhance therapeutic outcomes, and help develop non-invasive diagnostics. We compared the proteomic profiles of whole-cell and exosomal samples of representative breast cancer cell subtypes to evaluate the potential of extracellular vesicles as non-invasive disease biomarkers in liquid biopsies. Overall, differentially-expressed proteins in whole-cell and exosome samples (which included markers for invasion, metastasis, angiogenesis, and drug resistance) effectively discriminated subtypes; furthermore, our results confirmed that the proteomic profile of exosomes reflects breast cancer cell-of-origin, which underscores their potential as disease biomarkers. Our study will contribute to identifying biomarkers that support breast cancer patient stratification and developing novel therapeutic strategies. We include an open, interactive web tool to explore the data as a molecular resource that can explain the role of these protein signatures in breast cancer classification., This study was supported by the European Research Council (grant ERC-CoG-2014-648831 MyNano ) and the H2020 EU-OpenScreen-Drive project (grant agreement No. 823893). Our screening platform is part of the European Infrastructure, ERIC EUOpenScreen, and the Excellence Network, TeNTaCLES (Translational NeTwork for the CLinical application of Extracellular Vesicle-Tentacles-RED2018-102411-T). This research was also supported by the Spanish Ministry of Science and Innovation (PID2019-108806RBI00; PID2020-117211GB-I00; PID2021-124430OA-I00 funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and by FEDER, UE; and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, IMP/00019), co-funded by ERDF and CIBERONC (project n. CB22/12/00048). The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia, which belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. Agreement 2019 between IVO and the Association Mou-te per elles.